Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EBOS Group Limited ( (AU:EBO) ) has provided an announcement.
EBOS Group Limited has announced the acquisition of 3,000 ordinary shares by Director Elizabeth Coutts, increasing her shareholding from 37,112 to 40,112 shares. This transaction, valued at approximately NZD 87,903.73, reflects ongoing confidence in the company’s market positioning and potential growth, potentially impacting stakeholder perceptions positively.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care sectors, providing a range of products and services across these industries. The company focuses on distributing healthcare, medical, and pharmaceutical products, as well as veterinary products and pet care items, serving markets primarily in Australia and New Zealand.
Average Trading Volume: 135,982
Technical Sentiment Signal: Sell
Current Market Cap: A$5.19B
For an in-depth examination of EBO stock, go to TipRanks’ Overview page.